4.5 Article

Long-term outcomes after intervention for pulmonary atresia with intact ventricular septum

Journal

HEART
Volume 105, Issue 13, Pages 1007-1013

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/heartjnl-2018-314124

Keywords

pulmonary atresia; congenital heart defect; congenital heart surgery; long-term outcomes

Funding

  1. National Heart, Lung, and Blood Institute [R01 HL122392]

Ask authors/readers for more resources

Objective Pulmonary atresia with intact ventricular septum (PA/IVS) can be treated by various operative and catheter-based interventions. We aim to understand the long-term transplant-free survival of patients with PA/IVS by treatment strategy. Methods Cohort study from the Pediatric Cardiac Care Consortium, a multi-institutional registry with prospectively acquired outcome data after linkage with the National Death Index and the Organ Procurement and Transplantation Network. Results Eligible patients underwent neonatal surgery or catheter-based intervention for PA/IVS between 1982 and 2003 (median follow-up of 16.7 years, IQR: 12.6-22.7). Over the study period, 616 patients with PA/IVS underwent one of three initial interventions: aortopulmonary shunt, right ventricular decompression or both. Risk factors for death at initial intervention included earlier birth era (1982-1992), chromosomal abnormality and atresia of one or both coronary ostia. Among survivors of neonatal hospitalisation (n=491), there were 99 deaths (4 post-transplant) and 10 transplants (median age of death or transplant 0.7 years, IQR: 0.3-1.8 years). Definite repair or last-stage palliation was achieved in the form of completed two-ventricle repair (n=201), one-and-a-half ventricle (n=39) or Fontan (n=96). Overall 20-year survival was 66%, but for patients discharged alive after definitive repair, it reached 97.6% for single-ventricle patients, 90.9% for those with one-and-a-half ventricle and 98.0% for those with complete two-ventricle repair (log-rank p=0.052). Conclusions Transplant-free survival in PA/IVS is poor due to significant infantile and interstage mortality. Survival into early adulthood is excellent for patients reaching completion of their intended path independent of type of repair.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Are Mechanical Prostheses Valid Alternatives to the Ross Procedure in Young Children Under 6 Years Old?

Bahaaldin Alsoufi, Jessica H. Knight, James St Louis, Geetha Raghuveer, Lazaros Kochilas

Summary: The study found that aortic valve replacement in young children presents technical difficulties and potential risks. Mechanical prostheses are less commonly used compared to the Ross operation. Although there were no significant differences in hospital mortality and 15-year transplant-free survival between Ross and MP recipients, long-term follow-up revealed lower survival rates in the MP group, with a higher need for redo aortic valve replacement.

ANNALS OF THORACIC SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Long-term Outcomes of Children Operated on for Anomalous Left Coronary Artery From the Pulmonary Artery

Amanda S. Thomas, Alice Chan, Bahaaldin Alsoufi, Jeffrey M. Vinocur, Lazaros Kochilas

Summary: This study examined the outcomes of children who underwent ALCAPA surgery. The results showed that coronary artery reimplantation had a positive impact on long-term survival, and performing MV surgery for moderate/severe MR reduced the risk of in-hospital mortality. However, the severity of MR was not associated with in-hospital or longer-term outcomes.

ANNALS OF THORACIC SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Long-term outcomes after repair for anomalous right coronary artery from the pulmonary artery

Andrew Tran, Lazaros Kochilas, Amanda S. Thomas, Varun Aggarwal

Summary: This study evaluated the outcomes of patients who underwent surgical repair for ARCAPA within the Pediatric Cardiac Care Consortium (PCCC). The study found that patients had excellent outcomes after surgery, with good survival rates even up to 25 years of follow-up.

CARDIOLOGY IN THE YOUNG (2023)

Article Cardiac & Cardiovascular Systems

Multicentre comparative analysis of long-term outcomes after aortic valve replacement in children

Jessica H. Knight, Amber Leila Sarvestani, Chizitam Ibezim, Elizabeth Turk, Courtney E. McCracken, Bahaaldin Alsoufi, James St Louis, James H. Moller, Geetha Raghuveer, Lazaros K. Kochilas

Summary: This study analyzed the 25-year survival outcomes of children with congenital aortic valve disease who underwent different types of valve replacement surgeries, finding that pulmonic valve autograft provided the best long-term outcomes, while mechanical prosthetic valves were associated with a higher risk of mortality/transplant. Surgical outcomes may depend on the experience of the treatment center and patient selection.

HEART (2022)

Article Cardiac & Cardiovascular Systems

Outcomes Following Aortic Valve Replacement in Children With Conotruncal Anomalies

Bahaaldin Alsoufi, Jessica H. Knight, James St Louis, Geetha Raghuveer, Lazaros Kochilas

Summary: This study examined the long-term outcomes and factors affecting survival in children with repaired conotruncal anomalies who underwent aortic valve replacement (AVR). The results showed that 6% of patients died or received transplantation within 5 years after AVR, and 20% required reoperation. The 20-year transplant-free survival in the conotruncal anomalies group was lower than that in matched children with congenital non-conotruncal disease undergoing AVR. This suggests that long-term survival following AVR in children with conotruncal anomalies is inferior and is linked to the underlying cardiac defect.

WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Long-Term Outcomes of Cardiovascular Operations in Children With Connective Tissue Disorders

Amanda S. Thomas, Erin E. Falk, Sarah Mahoney, Jessica H. Knight, Lazaros K. Kochilas

Summary: This retrospective study examines the long-term outcomes of pediatric patients who underwent their first surgery for connective tissue-related cardiovascular conditions. The study found that non-infantile patients had relatively high postdischarge survival rates, but there was still a risk of death due to cardiovascular-related pathology.

AMERICAN JOURNAL OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Thirty-Year Survival After Cardiac Surgery in Children With Williams-Beuren Syndrome (from the Pediatric Cardiac Care Consortium Study)

Tawanda Zinyandu, Alejandro J. Montero, Amanda S. Thomas, Leandros Sassis, Pelagia Kefala-Karli, Jessica Knight, Lazaros K. Kochilas

Summary: This is a retrospective cohort study examining the 30-year survival outcomes of children with Williams-Beuren syndrome (WBS) who underwent interventions for congenital heart disease (CHD). The study found that the overall 30-year survival rate was 90%, with varying survival rates among different subgroups.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

Article Pediatrics

Worsening racial disparity in waitlist mortality for pediatric heart transplant candidates since the 2016 Pediatric Heart Allocation Policy revision

Lydia K. Wright, Robert J. Gajarski, Christina Phelps, Timothy M. Hoffman, Irene D. Lytrivi, Defne A. Magnetta, Fawwaz R. Shaw, Consuela Thompson, Molly Weisert, Deipanjan Nandi

Summary: The revision of the US Pediatric Heart Allocation Policy (PHAP) has led to increased waitlist mortality for non-white children, widening racial disparities.

PEDIATRIC TRANSPLANTATION (2023)

Review Pathology

Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis

Burcin Pehlivanoglu, Gizem Akkas, Bahar Memis, Olca Basturk, Michelle D. Reid, Burcu Saka, Nevra Dursun, Pelin Bagci, Serdar Balci, Juan Sarmiento, Shishir K. Maithel, Sudeshna Bandyopadhyay, Oscar Tapia Escalona, Juan Carlos Araya, Hector Losada, Michael Goodman, Jessica Holley Knight, Juan Carlos Roa, Volkan Adsay

Summary: Conflicting data exist regarding the frequency, prognosis and management of pT1b-gallbladder carcinoma (GBC). A study re-evaluated 473 GBC cases from the USA and Chile and found that only 5% of invasive GBCs were pT1b, with a 5-year survival rate of >90%. The study supports the inclusion of pT1b in the early GBC category and highlights the importance of accurate staging and long-term surveillance.

VIRCHOWS ARCHIV (2023)

Article Cardiac & Cardiovascular Systems

Racial and socioeconomic disparities in status exceptions for pediatric heart transplant candidates under the current US Pediatric Heart Allocation Policy

Lydia K. Wright, Stacey Culp, Robert J. Gajarski, Deipanjan Nandi

Summary: The revision of the US Pediatric Heart Allocation Policy in 2016 led to an increased demand for status exceptions, with potential disparities based on race and socioeconomic status affecting waitlist outcomes. By analyzing data from the Scientific Registry for Transplant Recipients, it was found that race and neighborhood SES were associated with the use of exceptions in Era 2, leading to worsened racial disparities in waitlist mortality among children with lower priority status.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Pediatrics

Narrowing the Survival Gap: Trends in Survival of Individuals with Down Syndrome with and without Congenital Heart Defects Born 1979 to 2018

Lydia K. Wright, Erin B. Stallings, Janet D. Cragan, Laura J. Pabst, Clinton J. Alverson, Matthew E. Oster

Summary: This study evaluated the survival rates of individuals with Down syndrome (DS) and congenital heart defects (CHDs) born from 1979 to 2018. The findings showed that the 5-year survival rate for DS individuals with CHDs has improved over the past decades and approached the survival rate of DS individuals without CHDs. It was also observed that CHDs did not significantly affect the mortality rate of DS individuals born in 2010 or later.

JOURNAL OF PEDIATRICS (2023)

Article Cardiac & Cardiovascular Systems

Novel uses for implanted haemodynamic monitoring in adults with subaortic right ventricles

William H. Marshall, May Ling Mah, Jennifer Desalvo, Saurabh Rajpal, Lauren T. Lastinger, Arash Salavitabar, Aimee K. Armstrong, Darren Berman, Brent Lampert, Lydia K. Wright, Jenne Hickey, Rachel Metzger, Deipanjan Nandi, Robert Gajarski, Curt J. Daniels

Summary: This study describes novel uses of implantable invasive hemodynamic monitoring (IHM) in patients with subaortic right ventricles (sRV), which may minimize the need for serial catheterizations and improve management in a population where pulmonary hypertension (PH) is prevalent. The findings suggest that IHM can be used for medical therapy titration, medical management after ventricular assist device, and serial monitoring of pulmonary artery pressures. There were low rates of heart failure hospitalization and device-related complications, indicating that IHM is a safe and effective tool in this patient population.

HEART (2023)

No Data Available